Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery

British Journal of Anaesthesia

Volumn 85, Issue 5, 2000, Pages 690-695

  Treggiari Venzi, M M ^a   Waeber, J L ^a   Perneger, T V ^a   Suter, P M ^b   Adamec, R ^a   Romand, J A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

Heart, arrhythmia, antiarrythmics; Heart, arrhythmia, supraventricular; Surgery, cardiovascular

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; DIGOXIN; FENTANYL; MAGNESIUM; MAGNESIUM SULFATE; METOPROLOL; MIDAZOLAM; MORPHINE; PANCURONIUM BROMIDE; PLACEBO; SODIUM CHLORIDE; VASOACTIVE AGENT;

ADULT; AGED; AGING; ANTIARRHYTHMIC ACTIVITY; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; COST BENEFIT ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; HYPOMAGNESEMIA; HYPOTENSION; INCIDENCE; INTENSIVE CARE; LENGTH OF STAY; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0033754351     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/85.5.690     Document Type: Article

References (24)

1. Atrial fibrillation and flutter after coronary artery bypass surgery: Epidemiology, risk factors and preventive trials
2. Atrial arrhythmias after cardiothoracic surgery
3. Relationship between atrioventricular arrhythmias and the concentration of K+ ion in cardioplegic solution
4. Peri-operative supraventricular arrhythmias in coronary bypass surgery
5. Conduction block after cardioplegic arrest: Prevention by augmented atrial hypothermia
6. Hazards of postoperative atrial arrhythmias
7. Atrial fibrillation after cardiac surgery: A major morbid event?
8. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: Results of a prospective, placebo-controlled study
9. Amiodarone prophylaxis for tachycardias after coronary artery surgery: A randomised, double blind, placebo controlled trial
10. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery
11. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting
12. Magnesium and arrhythmias after coronary artery bypass surgery
13. Arrhythmia prophylaxis after coronary artery surgery. A randomised controlled trial of intravenous magnesium chloride
14. The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation
15. Amiodarone-related postoperative adult respiratory distress syndrome
16. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized controlled trials
17. The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery
18. Supraventricular arrhythmias following coronary artery bypass. The effect of preoperative digitalis
19. Low-dose amiodarone-related complications after cardiac operations
20. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial
21. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting
22. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly?
23. Right coronary artery stenosis: An independent predictor of atrial fibrillation after coronary artery bypass surgery
24. Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations